A Phase 2 Study of Isatuximab in Combination With Pomalidomide and Dexamethasone in MM Patients Who Received One Prior Line of Therapy Containing Lenalidomide and a Proteasome Inhibitor

NCT05298683 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

108

Enrollment

OTHER

Sponsor class

Conditions

Multiple Myeloma
Renal Impairment
Neoplasms, Plasma Cell
Neoplasms by Histologic Type
Neoplasms
Paraproteinemias
Blood Protein Disorders
Hematologic Diseases

Interventions

DRUG: Isatuximab
DRUG: Pomalidomide
DRUG: Dexamethasone
DRUG: Acetaminophen (paracetamol)
DRUG: Ranitidine (or equivalent)
DRUG: Diphenhydramine (or equivalent)

Sponsor

Hellenic Society of Hematology

Collaborators

[object Object]